Cargando…

Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity

Rationale: Hypoxia induces leptin gene expression in human adipocytes via hypoxia-inducible factors (HIF-α/β). Under ambient moderate hypoxia, leptin in adipocytes is elevated for at least 14 days. Leptin is supposedly involved in the reduced food intake, increased utilization of fatty acids for ene...

Descripción completa

Detalles Bibliográficos
Autores principales: Rausch, Linda K., Hofer, Maximilian, Pramsohler, Stephan, Kaser, Susanne, Ebenbichler, Christoph, Haacke, Sven, Gatterer, Hannes, Netzer, Nikolaus C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200908/
https://www.ncbi.nlm.nih.gov/pubmed/30405530
http://dx.doi.org/10.3389/fendo.2018.00615
_version_ 1783365421940867072
author Rausch, Linda K.
Hofer, Maximilian
Pramsohler, Stephan
Kaser, Susanne
Ebenbichler, Christoph
Haacke, Sven
Gatterer, Hannes
Netzer, Nikolaus C.
author_facet Rausch, Linda K.
Hofer, Maximilian
Pramsohler, Stephan
Kaser, Susanne
Ebenbichler, Christoph
Haacke, Sven
Gatterer, Hannes
Netzer, Nikolaus C.
author_sort Rausch, Linda K.
collection PubMed
description Rationale: Hypoxia induces leptin gene expression in human adipocytes via hypoxia-inducible factors (HIF-α/β). Under ambient moderate hypoxia, leptin in adipocytes is elevated for at least 14 days. Leptin is supposedly involved in the reduced food intake, increased utilization of fatty acids for energy production and possible weight loss observed at high altitudes. Literature on adiponectin and visfatin in high altitude is inconsistent with reports of elevated levels and non-elevated levels. Exercise in hypoxia studies in obese subjects have shown a significant weight loss after up to 3 weeks, but it is unclear if this effect holds up for longer time periods. Therefore, we aimed to investigate 32 obese subjects completing 52 exercise and rest sessions within 8 months at either moderate or sham hypoxia and to analyze leptin, adiponectin, and visfatin mRNA-expression at different time points of exposure. Methods: Abdominal subcutaneous fat biopsies were taken from 32 obese subjects before, after 3 months and after 8 months of intervention. Subjects were randomly divided into two groups and exercised at moderate intensity at two different study sites twice a week. The IG was exposed to normobaric hypoxia (FiO(2): 14.0 ± 0.2%,) at exercise and at rest (FiO(2): 12.0 ± 0.2%) and the CG to sham hypoxia. Quantitative real-time polymerase chain reaction (qPCR) was used in order to determine mRNA-levels of leptin, adiponectin, and visfatin. Results: No differences in leptin levels after 3 and 8 months compared to baseline and between groups were found. There was no significant difference regarding adiponectin or visfatin at any time point compared to baseline in the hypoxia group, but an increase after 3 months was seen in the control group at normoxia compared to the hypoxia group (adiponectin: p = 0.029 and visfatin: p = 0.014). Conclusion: In this first several months' duration randomized sham controlled hypoxia exercise and rest study with obese subjects, we found no time extended leptin mRNA-expression in subjects under hypoxia after 3 and 8 months compared to baseline levels. Moderate exercise in normoxia not in hypoxia leads to elevated adiponectin and visfatin levels after 3 months.
format Online
Article
Text
id pubmed-6200908
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62009082018-11-07 Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity Rausch, Linda K. Hofer, Maximilian Pramsohler, Stephan Kaser, Susanne Ebenbichler, Christoph Haacke, Sven Gatterer, Hannes Netzer, Nikolaus C. Front Endocrinol (Lausanne) Endocrinology Rationale: Hypoxia induces leptin gene expression in human adipocytes via hypoxia-inducible factors (HIF-α/β). Under ambient moderate hypoxia, leptin in adipocytes is elevated for at least 14 days. Leptin is supposedly involved in the reduced food intake, increased utilization of fatty acids for energy production and possible weight loss observed at high altitudes. Literature on adiponectin and visfatin in high altitude is inconsistent with reports of elevated levels and non-elevated levels. Exercise in hypoxia studies in obese subjects have shown a significant weight loss after up to 3 weeks, but it is unclear if this effect holds up for longer time periods. Therefore, we aimed to investigate 32 obese subjects completing 52 exercise and rest sessions within 8 months at either moderate or sham hypoxia and to analyze leptin, adiponectin, and visfatin mRNA-expression at different time points of exposure. Methods: Abdominal subcutaneous fat biopsies were taken from 32 obese subjects before, after 3 months and after 8 months of intervention. Subjects were randomly divided into two groups and exercised at moderate intensity at two different study sites twice a week. The IG was exposed to normobaric hypoxia (FiO(2): 14.0 ± 0.2%,) at exercise and at rest (FiO(2): 12.0 ± 0.2%) and the CG to sham hypoxia. Quantitative real-time polymerase chain reaction (qPCR) was used in order to determine mRNA-levels of leptin, adiponectin, and visfatin. Results: No differences in leptin levels after 3 and 8 months compared to baseline and between groups were found. There was no significant difference regarding adiponectin or visfatin at any time point compared to baseline in the hypoxia group, but an increase after 3 months was seen in the control group at normoxia compared to the hypoxia group (adiponectin: p = 0.029 and visfatin: p = 0.014). Conclusion: In this first several months' duration randomized sham controlled hypoxia exercise and rest study with obese subjects, we found no time extended leptin mRNA-expression in subjects under hypoxia after 3 and 8 months compared to baseline levels. Moderate exercise in normoxia not in hypoxia leads to elevated adiponectin and visfatin levels after 3 months. Frontiers Media S.A. 2018-10-18 /pmc/articles/PMC6200908/ /pubmed/30405530 http://dx.doi.org/10.3389/fendo.2018.00615 Text en Copyright © 2018 Rausch, Hofer, Pramsohler, Kaser, Ebenbichler, Haacke, Gatterer and Netzer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Rausch, Linda K.
Hofer, Maximilian
Pramsohler, Stephan
Kaser, Susanne
Ebenbichler, Christoph
Haacke, Sven
Gatterer, Hannes
Netzer, Nikolaus C.
Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity
title Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity
title_full Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity
title_fullStr Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity
title_full_unstemmed Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity
title_short Adiponectin, Leptin and Visfatin in Hypoxia and its Effect for Weight Loss in Obesity
title_sort adiponectin, leptin and visfatin in hypoxia and its effect for weight loss in obesity
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200908/
https://www.ncbi.nlm.nih.gov/pubmed/30405530
http://dx.doi.org/10.3389/fendo.2018.00615
work_keys_str_mv AT rauschlindak adiponectinleptinandvisfatininhypoxiaanditseffectforweightlossinobesity
AT hofermaximilian adiponectinleptinandvisfatininhypoxiaanditseffectforweightlossinobesity
AT pramsohlerstephan adiponectinleptinandvisfatininhypoxiaanditseffectforweightlossinobesity
AT kasersusanne adiponectinleptinandvisfatininhypoxiaanditseffectforweightlossinobesity
AT ebenbichlerchristoph adiponectinleptinandvisfatininhypoxiaanditseffectforweightlossinobesity
AT haackesven adiponectinleptinandvisfatininhypoxiaanditseffectforweightlossinobesity
AT gattererhannes adiponectinleptinandvisfatininhypoxiaanditseffectforweightlossinobesity
AT netzernikolausc adiponectinleptinandvisfatininhypoxiaanditseffectforweightlossinobesity